Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2015Chemical Society ReviewsOpen Access

Ferrocifen type anti cancer drugs

View Full Paper
Ask AI
Bookmark
Share

Authors

GJGérard JaouenAVAnne VessièresSTSiden Top

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jaouen et al. (2015) studied this question.

synapsesocial.com/papers/69ffbac0831589f3542da4d5https://doi.org/10.1039/c5cs00486a
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evidence for Targeting Thioredoxin Reductases with Ferrocenyl Quinone Methides. A Possible Molecular Basis for the Antiproliferative Effect of Hydroxyferrocifens on Cancer Cells2014 · 114 citations
  2. 2Ferrocene‐Mediated Proton‐Coupled Electron Transfer in a Series of Ferrocifen‐Type Breast‐Cancer Drug Candidates2005 · 402 citations
  3. 3Discovery of novel SERMs with a ferrocenyl entity based on the oxabicyclo[2.2.1]heptene scaffold and evaluation of their antiproliferative effects in breast cancer cells2012 · 29 citations
  4. 4Deciphering the Activation Sequence of Ferrociphenol Anticancer Drug Candidates2012 · 77 citations
  5. 5Enantioselective Synthesis of Ferrocenyl Nucleoside Analogues with Apoptosis-Inducing Activity2006 · 83 citations